About HELEX INC.
Helex is a US and India-based early preclinical biotechnology company developing genomic medicines for high-burden kidney diseases, focusing on advanced therapeutics for genetic kidney conditions like Autosomal Dominant Polycystic Kidney Disease.
Development of genomic medicines for genetic kidney diseasesProprietary lipid nanoparticle technology for targeted delivery of therapeutic cargoEpic-Cure™ technology for de-risked drug designGene editing-based therapeutics with focus on safety and precisionLeveraging data, machine learning, and epigenetics to accelerate drug development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to HELEX INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.